APA (7th ed.) Citation

JS, D., Jr, H. F., MP, N., S, M., S, W., SF, L., . . . DM, O. (2021). Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma. Frontiers in oncology, 11, 669071. https://doi.org/10.3389/fonc.2021.669071

Chicago Style (17th ed.) Citation

JS, Durgin, et al. "Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma." Frontiers in Oncology 11 (2021): 669071. https://doi.org/10.3389/fonc.2021.669071.

MLA (9th ed.) Citation

JS, Durgin, et al. "Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma." Frontiers in Oncology, vol. 11, 2021, p. 669071, https://doi.org/10.3389/fonc.2021.669071.